Cardiol Therapeutics (CRDL) Competitors $1.07 -0.28 (-20.74%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$1.11 +0.04 (+3.74%) As of 06:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRDL vs. KOD, PGEN, PRTC, RGNX, SVRA, KMDA, CMPX, PVLA, FULC, and GOSSShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Kodiak Sciences (KOD), Precigen (PGEN), PureTech Health (PRTC), REGENXBIO (RGNX), Savara (SVRA), Kamada (KMDA), Compass Therapeutics (CMPX), Palvella Therapeutics (PVLA), Fulcrum Therapeutics (FULC), and Gossamer Bio (GOSS). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Its Competitors Kodiak Sciences Precigen PureTech Health REGENXBIO Savara Kamada Compass Therapeutics Palvella Therapeutics Fulcrum Therapeutics Gossamer Bio Kodiak Sciences (NASDAQ:KOD) and Cardiol Therapeutics (NASDAQ:CRDL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership. Which has more volatility and risk, KOD or CRDL? Kodiak Sciences has a beta of 2.41, suggesting that its stock price is 141% more volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Which has higher earnings and valuation, KOD or CRDL? Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$176.21M-$3.63-2.26Cardiol TherapeuticsN/AN/A-$26.77M-$0.34-3.15 Do insiders and institutionals have more ownership in KOD or CRDL? 89.1% of Kodiak Sciences shares are held by institutional investors. Comparatively, 12.5% of Cardiol Therapeutics shares are held by institutional investors. 45.9% of Kodiak Sciences shares are held by company insiders. Comparatively, 5.3% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is KOD or CRDL more profitable? Kodiak Sciences' return on equity of -115.71% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -115.71% -54.17% Cardiol Therapeutics N/A -209.63%-141.09% Do analysts rate KOD or CRDL? Kodiak Sciences presently has a consensus price target of $9.00, suggesting a potential upside of 9.62%. Cardiol Therapeutics has a consensus price target of $8.00, suggesting a potential upside of 647.66%. Given Cardiol Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Cardiol Therapeutics is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Cardiol Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media refer more to KOD or CRDL? In the previous week, Kodiak Sciences had 1 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 2 mentions for Kodiak Sciences and 1 mentions for Cardiol Therapeutics. Kodiak Sciences' average media sentiment score of 0.84 beat Cardiol Therapeutics' score of 0.00 indicating that Kodiak Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kodiak Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardiol Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryKodiak Sciences beats Cardiol Therapeutics on 8 of the 14 factors compared between the two stocks. Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$111.61M$2.52B$5.57B$9.47BDividend YieldN/A1.78%4.31%4.17%P/E Ratio-3.1519.5129.4423.99Price / SalesN/A695.09448.01188.34Price / CashN/A162.3535.8458.51Price / Book4.865.208.075.58Net Income-$26.77M$31.61M$3.26B$265.35M7 Day Performance-28.19%0.90%0.48%-0.07%1 Month Performance-26.21%6.97%4.86%1.76%1 Year Performance-44.27%6.15%30.22%25.39% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol Therapeutics2.2698 of 5 stars$1.07-20.7%$8.00+647.7%-46.8%$111.61MN/A-3.1520News CoverageUpcoming EarningsGap DownHigh Trading VolumeKODKodiak Sciences2.4352 of 5 stars$8.24-6.8%$9.00+9.2%+228.4%$466.43MN/A-2.2790Upcoming EarningsPGENPrecigen4.0069 of 5 stars$1.58+0.6%$6.00+279.7%+35.6%$463.43M$3.92M-2.82190News CoverageUpcoming EarningsOptions VolumePRTCPureTech Health1.4558 of 5 stars$19.09+0.1%$45.00+135.8%-13.9%$458.15M$4.83M0.00100RGNXREGENXBIO4.0339 of 5 stars$8.79-1.9%$31.63+259.8%-35.1%$449.44M$83.33M-2.83370SVRASavara2.0231 of 5 stars$2.66+3.1%$5.60+110.5%-34.4%$445.92MN/A-5.5420Upcoming EarningsHigh Trading VolumeKMDAKamada4.4196 of 5 stars$7.68-0.5%$13.00+69.3%+32.0%$443.94M$160.95M26.48360News CoveragePositive NewsUpcoming EarningsCMPXCompass Therapeutics2.905 of 5 stars$3.20+0.6%$12.67+295.8%+202.2%$439.74M$850K-7.8020Upcoming EarningsPVLAPalvella Therapeutics2.7292 of 5 stars$39.87+3.2%$47.50+19.1%N/A$426.97M$42.81M-3.30N/ANews CoverageUpcoming EarningsAnalyst ForecastAnalyst RevisionGap UpFULCFulcrum Therapeutics1.4864 of 5 stars$7.81flat$6.29-19.5%-21.8%$421.58M$80M-111.56100Gap DownGOSSGossamer Bio3.9389 of 5 stars$1.98+7.6%$8.25+316.7%+137.7%$418.24M$114.70M-8.61180News CoverageEarnings ReportUpcoming EarningsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies KOD Alternatives PGEN Alternatives PRTC Alternatives RGNX Alternatives SVRA Alternatives KMDA Alternatives CMPX Alternatives PVLA Alternatives FULC Alternatives GOSS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRDL) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts